(Total Views: 394)
Posted On: 05/05/2021 12:46:01 PM
Post# of 145886
"Trial site News summary;
"LERONLIMAB is an excellent drug for hospitalized patients that reduces FATALITY Risk by 85%. It is given once a week for 4 weeks."
"LERONLIMAB is an excellent drug for hospitalized patients that reduces FATALITY Risk by 85%. It is given once a week for 4 weeks."
(3)
(1)